Kukjeon국전

Quick answers about Kukjeon

What does Kukjeon do?

The company manufactures and sells pharmaceuticals and advanced materials, with two business segments: a pharmaceutical segment that synthesizes, imports, distributes and sells active pharmaceutical ingredients and related products, and a materials segment that develops, produces and sells high-performance specialty chemical materials for advanced industries such as OLED displays, semiconductor packaging and automotive electronics. Its pharmaceutical operations serve clients in the generic, new drug and improved drug development stages, and its materials business supplies customers in the semiconductor, display and electronics sectors. Its production facilities are located in Hwaseong, Gyeonggi Province, and Eumseong, Chungbuk, South Korea.

What is the market cap of Kukjeon?

The market capitalisation of Kukjeon was ₩112B at the close on Oct 29, 2026.

Who are the largest shareholders of Kukjeon?

According to the latest official filings, the largest reported holders are Hong Jong-ho (52.23%, as of Oct 6, 2026); Hong Jong-hun (10.04%, as of Jul 24, 2026); Rhinos Asset Management (3.20%, as of May 7, 2026).

When is the next earnings report from Kukjeon?

Korean companies rarely announce results dates in advance. Based on when Kukjeon filed the same report in past years, its next 3q results is expected around Nov 13, 2026.